Expert Interview
Delving into the Phase 2b ANTHEM-UC clinical trial results of icotrokinra in patients with ulcerative colitis.
Ticker(s): PTGXInstitution: Unviersity of Wisconsin
Associate Professor in the Division of Gastroenterology and Hepatology at the University of Wisconsin, specializing in inflammatory bowel diseases like Crohn’s disease, ulcerative colitis, and pouchitis.
Physician-scientist researching vaccine-preventable illness risks and vaccine responses in immunosuppressed IBD patients, with publications in Inflammatory Bowel Diseases.
Medical Director of the Crohn’s Colitis Foundation Patient Support Group, recognized with the 2016 AGA Early Stage Investigator Award, and active in AGA, ASGE, and CCFA.
Are You Interested In These Questions?
Slingshot Insights Explained
- Call Date
- Jun 23, 2025
- Call Time
- 06:45 PM EDT
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
